Stages of multiple myeloma

Last medical review:

Staging describes or classifies a cancer based on how much cancer there is in the body and where it is when first diagnosed. This is often called the extent of cancer. Cancers that form solid tumours are given numbered stages based on the size of the tumour and if the cancer has spread to lymph nodes or other parts of the body.

Multiple myeloma is not staged in the same way as other types of cancer. Multiple myeloma is a cancer of the plasma cells. Plasma cells are a type of white blood cell that makes antibodies (also called immunoglobulins) to help the body fight infection. Blood cells, including plasma cells, are formed in the bone marrow throughout the body.

To determine the stage of multiple myeloma, the healthcare team will do blood chemistry tests and cytogenetic tests. They will look for:

  • the level of a protein in plasma( called albumin)
  • the level of a protein on the surface of myeloma cells that is involved in the immune response( called beta-2-microglobulin)
  • the level of lactate dehydrogenase in the blood
  • high-risk chromosome changes, such as a missing part of chromosome 17 (called a 17p deletion), a rearranged chromosome 4 (called a translocation) or a rearranged chromosome 14

Knowing the stage helps your healthcare team understand how multiple myeloma will likely affect your body, plan what treatments should start right away and estimate the outcome (prognosis).

Revised International Staging System

The staging system most often used in Canada for multiple myeloma is the Revised International Staging System. It has 3 stages – stage 1, stage 2 and stage 3. Often the stages are written as the Roman numerals I, II and III. Generally, the higher the stage number, the more advanced the cancer.

Find out more about staging cancer.

Stage 1

The albumin level is 3.5 g/dL or more.

The beta-2-microglobulin level is less than 3.5 mg/L.

There are no high-risk chromosome changes.

The lactate dehydrogenase level is normal.

Stage 2

The lab test results do not fit the criteria for stage 1 or stage 3.

Stage 3

The beta-2-microglobulin level is greater than 5.5 mg/L.

There are high-risk chromosome changes or the lactate dehydrogenase level is elevated.

Relapsed multiple myeloma

Relapsed multiple myeloma means that the cancer has come back after it has been treated.

Expert review and references

  • Guido Lancman, MD, MSc
  • Mikhael J, Ismaila N, Cheung MC, et al. Treatment of multiple myeloma: ASCO and CCO joint clinical practice guideline. Journal of Clinical Oncology. 2019: 37(14):1228–1263.
  • Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk-stratification and management. American Journal of Hematology. 2022: 97(8):1086–1107.

Your trusted source for accurate cancer information

With just $5 from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

If everyone reading this gave just $5, we could achieve our goal this month to fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2025 Canadian Cancer Society